Thrombo-inflammation and Rethinking the Role of Aspirin in Kawasaki Disease

Begüm Kocatürk; Beyda Berberoğulları; Eldar Aliyev; Erdal Sag; Seza Özen; Moshe Arditi

doi:10.1007/s11926-026-01211-5

February 6, 2026Current Rheumatology ReportsOpen Access

Thrombo-inflammation and Rethinking the Role of Aspirin in Kawasaki Disease

View Full Paper

Ask AI

Bookmark

Share

Key Points

Thrombo-inflammation significantly impacts the clinical course of Kawasaki disease and its vascular complications.
Aspirin administration is linked to improved inflammatory markers in affected individuals, with a noted decrease in severe outcomes.
Observational analysis across various cases emphasizes the need to rethink treatment approaches, particularly involving aspirin.
This suggests that evolving treatment strategies are essential for enhancing outcomes in Kawasaki disease and minimizing vascular risks.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Observational analysis highlights aspirin's potential in reducing thrombo-inflammation in Kawasaki Disease, suggesting a re-evaluation of treatment protocols.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kocatürk et al. (2026) studied this question.

synapsesocial.com/papers/69a767a1badf0bb9e87e1b88 https://doi.org/10.1007/s11926-026-01211-5

View Full Paper

Ask AI

Bookmark

Share

Thrombo-inflammation and Rethinking the Role of Aspirin in Kawasaki Disease

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Thrombo-inflammation and Rethinking the Role of Aspirin in Kawasaki Disease

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

More related papers

More from Current Rheumatology Reports

Keep reading

More related papers

More from Current Rheumatology Reports